Physicians and Faculty

chungc.jpg  

Chung Taik Chung, M.D.

Professor, Radiation Oncology
628 University Hospital
Upstate Medical University
750 East Adams Street
Syracuse, NY 13210

Education and Clinical Training

M.D.: 1967, Yonsei University, Seoul, Korea
Residency: Radiation Oncology, 1974, SUNY Health Science Center at Syracuse

Clinical Specialty

Radiation Oncology, Certified: 1974

Research Program and Department Affiliations

Radiation Oncology

Research Interests

Treatment of advanced head and neck cancer with altered fractionation radiation therapy in combination with chemotherapy.

Research Abstract

Treatment of Advanced Head and Neck Cancer with Altered Fractionation Radiotherapy in Combination with Chemotherapy. With S. Lemke, R. Young, R. Kellman, R.. Kelley, S. Tatum, J. Bogart, J. Aronowitz

For advanced cancers of the head and neck, surgery in combination with irradiation has become the mainstay of treatment. However, survival results are still disappointing, and functional results may be undesirable. Efforts to improve the results of these treatments as well as to preserve the organs have led to an increasing role for chemotherapy. We have completed preliminary pilot studies of neoadjuvant chemotherapy with carboplatin, 5-fluorouracil and leucovorin, followed by altered fractionation radiotherapy with concurrent taxol. In altered fractionation radiotherapy, the second half of the treatments are given twice daily in an attempt to increase local tumor control. This protocol has special merits, with neoadjuvant chemotherapy, which may shrink the tumor, and may also have a role in preventing distant metastases, and altered fractionation radiotherapy, which probably is superior to standard fractionation, with concurrent chemotherapy, which may enhance the radiation effect.

This profile was last updated on 06/11/2007

A short link is available for this profile:
http://www.upstate.edu/radonc/faculty.php?ID=chungc